
Mojoon Review
Best for: comprehensive concierge care
Premium-priced telehealth provider offering compounded semaglutide.
What the monthly price covers
Medication
Included
Provider visits
Not disclosed
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Mojoon is a solid telehealth option with balanced features and pricing.
Mojoon at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $450/mo
- What's included
- Medication · Shipping
- FDA status
- No FDA warning letter on record
How we scored Mojoon
Each dimension is scored algorithmically from Mojoon’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
5.7/10At $450/mo, Mojoon runs about 165% above the $170 median for GLP-1 providers.
Effectiveness25%
8.3/10Mojoon offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience; 3 platform features disclosed.
Trust & Safety15%
7.5/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-03).
Accessibility10%
6.3/10Mojoon's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.1/10Mojoon provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Mojoon review
Last checked 2026-06-03- Confirmed current pricing across 1 dose/plan tier
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Mojoon offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check Mojoon's current pricing and active discounts before you decide.
What we like
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Watch-outs
- Premium pricing relative to market
Mojoon: a Chinese-language GLP-1 service built for one specific audience
Mojoon is one of the few weight-loss telehealth platforms we've reviewed that isn't really trying to compete for the general English-speaking market at all. Its entire site runs in Chinese, and it's openly built to serve Chinese-speaking residents in the United States who want compounded GLP-1 care without the language barrier of a mainstream clinic. If you fit that description, Mojoon is genuinely worth a look — the bilingual support and discreet delivery solve a real problem. If you don't read Chinese, this almost certainly isn't the provider for you, and that's not a knock on the medicine so much as a plain statement of who it's designed for.
Who this is actually for
We want to be honest up front, because it changes the whole calculation. Mojoon's service, support, and ordering experience are oriented around Chinese-language patients. For someone navigating GLP-1 treatment in their first language, that's a meaningful advantage — fewer misunderstandings about dosing, side effects, and what to expect. But for an English-only patient, the same service that's a strength here becomes a daily friction point, and there are dozens of mainstream English-first providers that will be a smoother fit. So the first filter is simple: this is a strong option if you're a Chinese-speaking US resident, and a poor one if you're not.
What it costs and how the pricing works
Mojoon sits at the premium end of the market. Its compounded program runs about $450 a month in our record, which is well above the category median of $170 — you're paying a clear premium relative to the cheaper compounded services out there. There's no standing teaser or first-month promo rate to soften the entry, so what you see is roughly what you pay from the start. One thing to confirm directly: the medication price and the consultation fee appear to be listed separately on the site, so budget for the visit cost on top of the monthly medication rather than assuming it's all bundled into one number.
A note on accuracy: when we last checked the live site, the headline injectable figure looked lower than the rate in our pricing record, so there may be some drift between what's published today and what we have on file. Treat our number as a planning estimate and verify the current price in your own cart before committing. You can see how we weigh price against the rest of a provider's profile in our scoring methodology.
The medications and how they reach you
Mojoon's program is built on compounded semaglutide, offered as both an injection and an oral form, and its listing also reflects tirzepatide availability. These are compounded versions, not brand-name Ozempic, Wegovy, or Zepbound — an important distinction, because compounded drugs are not FDA-approved products and don't carry the same regulatory review as the branded pens. For many patients the appeal of compounded semaglutide is access and cost relative to brand list prices that can run well over a thousand dollars a month, but you should go in understanding exactly what you're getting.
Where Mojoon clearly put thought in is delivery. The medication ships directly to you, and the site specifically advertises free, unmarked, label-free packaging — discreet shipping that doesn't announce what's inside. For patients who value privacy around weight-loss treatment, that's a small but genuinely considerate touch, and it's the kind of detail that signals the service understands its audience.
What sets Mojoon apart
The real differentiator here isn't the drug — plenty of providers dispense compounded semaglutide. It's the combination of native Chinese-language care and a privacy-forward delivery model aimed squarely at a community that mainstream telehealth often overlooks. That focus is the whole point of the brand, and it's what would justify the premium price for the right patient: you're paying partly for a concierge-style experience in your own language rather than the absolute lowest sticker price.
- Native Chinese-language platform and support, not a translated afterthought
- Compounded semaglutide in both injectable and oral forms, with tirzepatide also listed
- Free, unmarked, discreet package delivery to your door
- LegitScript-certified, an independent check that the pharmacy operation is legitimate
- Broad reach across most of the country, with a couple of state exclusions
Trust, safety, and oversight
On the trust side, the most reassuring signal is that Mojoon is LegitScript-certified. That's a meaningful independent vetting standard for online pharmacies and telehealth operations, and it's not something every compounded-GLP-1 seller can claim. We have no FDA warning letters on file against Mojoon, and there are no compounding-partner red flags in our record. That said, the verification confidence here is moderate rather than high — the Chinese-language interface makes some details, like the exact split between medication and consult fees, harder to pin down from the outside, and the pricing drift we noted is a reminder to confirm specifics yourself. It's also worth knowing the service operates across most US states but excludes New Mexico and Mississippi, so check that your state is covered before you start.
Who should skip it
Skip Mojoon if you don't speak Chinese — the language orientation that makes it great for its target audience will work against you, and a mainstream English-first provider will serve you better. Skip it, too, if price is your top priority: at premium pricing well above the category median, this is not the value play, and budget-focused shoppers can find cheaper compounded semaglutide elsewhere. And if you specifically want FDA-approved brand-name medication rather than a compounded formulation, Mojoon isn't the right door — its program is compounded only.
The bottom line
Mojoon is a focused, slightly premium service that does one thing deliberately well: deliver compounded GLP-1 care, discreetly, to Chinese-speaking patients in the US. For that audience, the LegitScript certification, bilingual support, and unmarked shipping add up to a thoughtful, trustworthy-feeling experience that's hard to find anywhere else, and the higher price buys real convenience. For everyone else, the language barrier and premium cost mean you'll likely be happier with a mainstream provider. Match yourself honestly to the audience, confirm the current price and your state's eligibility, and you'll know quickly whether Mojoon is your provider or not.
Shopping around? Brightmeds ($325/month) and bmiMD ($99/month) are the nearest alternatives to Mojoon in our rankings.
Ready to start with Mojoon?
Starting at $450/month. See current pricing and start your free consultation.
Alternatives to Mojoon
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Mojoon review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Ready to start with Mojoon?
Starting at $450/month. See current pricing and start your free consultation.